Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
PHASE1
This is a first in human, open-label, multi-center Phase 1 / 2 study to eva...
90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome
PHASE1
This phase I trial is to find out the best dose, possible benefits and/or s...
Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent Thalassemia
PHASE2
Graft-versus-host disease (GVHD) is a major factor affecting the efficacy a...
Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host Disease
PHASE4
To investigate whether the addition of recombinant humanized anti-CD25 mono...
Status
Recruiting
Location
Beijing Children's Hospital Capital Medical University